Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

New ProLogis Report Concludes US and Canadian Industrial Property Markets are On the Mend

August 31, 2010 9:32 am | by Material Handling Industry of America | News | Comments

ProLogis recently announced the release of a new research report on the state of the industrial property markets in the United States and Canada, titled "On the Mend."The report is based on market statistics compiled from a variety of sources,

Ovatech closes successful birth control trial

August 31, 2010 8:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Ovatech Inc., a women's health tech startup in Auburndale, has completed a Phase 2 clinical trial of its non-hormonal, intravaginal contraceptive ring, called Ovaprene.

Magic-Seal Packaging Products to Introduce First Vytex® Natural Rubber Latex Napkin Rings

August 31, 2010 8:38 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Aug. 31 /- Vystar® Corporation (OTC Bulletin Board: VYST ), the exclusive creator of Vytex® Natural Rubber Latex (NRL), a multi-patented, all-natural raw material that contains significantly reduced levels of the antigenic proteins found in natural rubber latex (NRL),...

TOPICS:
Advertisement

Greenway Selected by Health Information Exchanges and Regional Physician Groups

August 31, 2010 8:38 am | by Bio-Medicine.Org | News | Comments

CARROLLTON, Ga., Aug. 31 /- Greenway Medical Technologies, Inc. today announced that four additional Health Information Exchange (HIE) programs, Independent Physician Associations (IPA) and regional medical centers have selected PrimeSuite® , the company's integrated electronic...

TOPICS:

Hill-Rom Appoints Scott Jeffers as Senior Vice President, Global Supply Chain

August 31, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

BATESVILLE, Ind., Aug. 31 /- Hill-Rom (NYSE: HRC ) today announced the appointment of Scott Jeffers as Senior Vice President, Global Supply Chain.  Currently serving as General Manager for Global Lean Enterprise at GE Healthcare, Jeffers will officially join Hill-Rom on September 13,...

TOPICS:

Invisible Bracelet Launches Nationwide Emergency Medical Notification Text Messaging Service

August 31, 2010 8:37 am | by Bio-Medicine.Org | News | Comments

TULSA, Okla., Aug. 31 /- When faced with a medical crisis, having the ability or presence of mind to personally communicate critical health information to emergency response teams may not be possible. 

TOPICS:

Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery

August 31, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 31 /- Masimo (Nasdaq: MASI ) announced today that a new randomized controlled trial published in Anesthesia & Analgesia shows that clinicians using Masimo Pleth Variability Index (PVI®) significantly improved fluid management and reduced lactate levels in...

TOPICS:

Summary Box: 3M buying ankle bracelet maker

August 31, 2010 7:45 am | by The Associated Press | News | Comments

THE DEAL: Manufacturing conglomerate 3M Co. has agreed to pay $230 million in cash for an Israeli company that makes technology for tracking people's movements.THE MOTIVE: 3M is increasingly stepping away from its Post-It and Scotch Tape roots in favor of technology that helps it grow faster. This...

Advertisement

Orthofix secures $300M 5-year credit facility

August 31, 2010 6:45 am | by The Associated Press | News | Comments

Medical device maker Orthofix International NV said Tuesday it has obtained a $300 million five-year credit facility.The new facility provides the company with a lower interest rate, more flexible terms, additional borrowing capacity and available credit compared with its previous deal.The...

What are the key trends in microfluidics for the next 5 years?

August 31, 2010 6:32 am | by I-Micronews | News | Comments

Yole Développement and its partner Institut fur Mikrotechnik Mainz GmbH (IMM) are glad to announce the workshop dedicated to the Microfluidics industry, on October 4 (2.00 PM to 5.00 PM)

Genzyme shareholders may hold buyout decision

August 31, 2010 5:31 am | by Mass High Tech: The Journal of New England Technology | News | Comments

French drug maker Sanofi-Aventis has promised to take its acquisition bid for Genzyme Corp. to its shareholders, after Genzyme management dismissed its offer of $69 per share. Genzyme has said it will urge shareholders to reject the offer.

3M buying maker of people tracking devices

August 31, 2010 4:45 am | by The Associated Press | News | Comments

Manufacturing conglomerate 3M says it has agreed to pay $230 million in cash for an Israeli company that makes technology used to keep track of people.The company, Attenti Holdings SA, makes systems that can be used, for example, to track the movements of people awaiting trial or are on...

Lower-dose heparin use during coronary procedure does not appear to reduce risk of major bleeding

August 31, 2010 4:37 am | by EurekAlert | News | Comments

(JAMA and Archives Journals) Patients with acute coronary syndromes initially treated with the anticoagulant fondaparinux who underwent a coronary procedure (such as balloon angioplasty) and received a lower dose of the anticoagulant heparin during the procedure did not have a...

TOPICS:

Repligen to Present at the Rodman & Renshaw Annual Global Investment Conference

August 31, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Aug. 31 /- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 13th, 2010 at 12:05 p.m. EDT...

TOPICS:

Actemra Post-Launch Success Continues to Gain Momentum with Broader Adoption Compared to Biologic Analog Launches and a Professional Marketing Campaign That Resonates with Rhe...

August 31, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

EXTON, Pa., Aug. 31 /- BioTrends has released the third and final wave of LaunchTrends®: ACTEMRA . Actemra (tocilizumab), marketed by Roche-Genentech, is the first humanized IL-6 receptor inhibitor agent approved for moderate-to-severe rheumatoid arthritis (RA) patients with an...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading